Human Growth Hormone Drugs Market Future Trends, Manufacturers Eli Lilly and Company, Ferring Holding SA,Genentech,GeneScience Pharmaceuticals,Merck KgaA,Novo Nordisk A/S,Pfizer

Human growth hormone is responsible for growth and regeneration among humans and also stimulates cell reproduction. However, deficiency of growth hormone is constantly on the rise. Advancements in technology including development of recombinant human growth hormone by the major players is boosting the market growth. Also, the leading companies are focusing on increasing their production capacity in order to increase supply in the rural areas.

Growth hormone deficiency is likely to account for the largest market share in terms of value. Towards the end of 2026, growth hormone deficiency is estimated to create an incremental opportunity of more than US$ 1,100 million between 2017 and 2026. Many companies are investing in research & development of long-acting hormonal therapy with lesser adverse effects. Furthermore, companies made an investment to increase the manufacturing capacity. For instance, Novo Nordisk invested multi-million dollar in Lebanon to increase supply in a rural community in 2016. This site will produce medicines to treat hemophilia and growth disorders.

Adult Growth Hormone Deficiency (AGHD) is increasing due to several factors such as pituitary tumors, neuropsychiatric-cognitive, neuromuscular, cardiovascular, skeletal abnormalities and metabolic abnormalities. Most of these disorders can be reversed with growth hormone therapy. It is expected that in the adult UK population at any given time, about one in every 10,000 people will have an adult onset growth hormone deficiency. The increasing usage and development of recombinant human growth hormone drugs; increasing adoption of growth hormone drugs, as anti-aging drug; and growing popularity of human growth hormone drugs, as performance enhancing drugs are the key trends in the global human growth hormone market. Human growth hormone is a peptide hormone, stimulating growth in children and adolescents, and is produced by the pituitary gland. It helps in the growth of bones and muscles by specific cellular differentiation. Apart from stimulating growth, the human growth hormone also regulates carbohydrate metabolism, protein metabolism and fat metabolism.

Request For Sample Copy:
http://bit.ly/2L0kz09

Some of the factors driving the growth of the global human growth hormone market are increasing demand for human growth hormone drugs, increasing incidences of human growth hormone deficiency diseases, growing geriatric population, and technological advancements, such as recombinant DNA technology for the development of human growth hormone drugs. In addition, several major players are investing heavily and collaborating among each other for the research and development of human growth hormone drugs, which is fueling the growth of the global human growth hormone market. However, stringent regulatory approvals, high cost of treatment, and adverse effects associated with the usage of synthetic human growth hormones are some of the factors restraining the growth of the global human growth hormone market to some extent.

The market is expected to experience robust growth due to the increasing prevalence of GH and long-acting growth hormone formulations in development. Rising aging population accompanied by high growth of serious chronic diseases would keep the demand for hGH drugs high and would act as the growth catalyst for the global market.

The global long-acting growth hormone market is estimated to increase at a commendable rate in future, which is mainly due to increase in research and development activities and increasing occurrence of pituitary dysfunction. TransCon is expected to dominate the market due to ease of use and high efficacy. The market will see a shift in the use of long-acting hormone drugs from daily basis products, positively impacting the market.

Inquire Before Buying :
http://bit.ly/2VlLFTj

About Worldwide Market Reports:
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. Worldwide Market Reports’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunitiesand shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1-415-871-0703 / +44-203-289-4040
Email: sales@worldwidemarketreports.com

This release was published on openPR.